Braskem
BAK
1.81
+0.04
+1.98%
Braskem
US · BAK
#3504 by market cap
1.81
+0.04
+1.98%
Live - 5344 symbols - heartbeat 406s ago
· 2026-10-08 10:11
Pre-market
1.68
-5.08%
After-hours
1.79
+1.13%
Overnight
1.78
+0.56%
- Market cap
- 719.26M
- P/E (TTM)i
- -0.65
- P/Bi
- -0.29
- EPSi
- -4.94
- Div yieldi
- 0.00%
- 52W posi
- 10%
Reader sentiment
Are you bullish or bearish on BAK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.29, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -8.65% YoY
Margins
- Gross margin
- 2.20%
- Operating margin
- -0.76%
- Net margin
- -13.97%
Key ratios & quality
- Enterprise valuei
- 56.95B
- Altman Z-Scorei
- 0.29
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 58.00B | 52.32B | 58.54B | 105.63B | 96.52B | 70.57B | 77.41B | 70.72B |
| Gross profit | 11.42B | 6.44B | 11.21B | 32.06B | 11.36B | 3.02B | 6.00B | 1.56B |
| Selling & admin expenses | 3.48B | 4.01B | 3.77B | 4.58B | 4.87B | 4.39B | 4.63B | 4.68B |
| Research & development | 219.26M | 247.73M | 250.65M | 297.00M | 374.00M | 383.00M | 463.00M | 460.00M |
| Operating profit | 7.79B | 169.09M | 7.19B | 27.18B | 6.11B | -1.75B | 904.00M | -534.00M |
| Pretax profit | 3.60B | -4.60B | -9.68B | 17.96B | 47.00M | -6.19B | -17.73B | -2.85B |
| Tax | 736.55M | -1.96B | -2.67B | 4.00B | 868.00M | -1.30B | -5.68B | 8.12B |
| Net profit | 2.87B | -2.64B | -7.02B | 13.96B | -821.00M | -4.89B | -12.05B | -10.96B |
| Basic EPS | 7 | -6 | -17 | 35 | -1 | -11 | -28 | -25 |
| Diluted EPS | 7.11 | -6.38 | -16.82 | 35.15 | -0.84 | -11.49 | -28.40 | -24.79 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 19.46B | 17.86B | 17.30B | 16.10B | 15.49B | 21.72B |
| Gross profit | 1.31B | 362.00M | 436.00M | -552.00M | 1.10B | 5.32B |
| Selling & admin expenses | 1.18B | 1.21B | 1.11B | 1.17B | 1.22B | 1.21B |
| Research & development | 126.00M | 108.00M | 121.00M | 105.00M | 102.00M | 103.00M |
| Operating profit | 1.00M | -958.00M | -798.00M | 1.22B | -217.00M | 4.00B |
| Pretax profit | 816.00M | -530.00M | -2.59B | -540.00M | 953.00M | 3.56B |
| Tax | 184.00M | -140.00M | -2.42B | 10.49B | -293.00M | 238.00M |
| Net profit | 632.00M | -390.00M | -174.00M | -11.03B | 1.25B | 3.32B |
| Basic EPS | 2 | -1 | 0 | -26 | 4 | 8 |
| Diluted EPS | 1.75 | -0.67 | -0.07 | -25.81 | 3.63 | 8.34 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 21.03B | 23.39B | 34.19B | 39.29B | 34.46B | 37.44B | 37.04B | 30.45B |
| Cash & ST investments | 7.91B | 8.49B | 17.49B | 12.17B | 14.76B | 19.14B | 16.77B | 11.84B |
| Inventory | 8.49B | 7.63B | 8.38B | 16.27B | 13.91B | 12.38B | 13.47B | 10.42B |
| Total assets | 58.81B | 68.13B | 86.08B | 92.56B | 88.05B | 91.74B | 101.58B | 81.88B |
| Total current liabilities | 22.77B | 16.22B | 28.39B | 25.19B | 24.19B | 24.49B | 28.27B | 40.22B |
| Short-term debt | 11.28B | 2.24B | 9.93B | 2.16B | 3.29B | 3.75B | 4.14B | 21.67B |
| Long-term debt | 26.61B | 40.10B | 48.22B | 49.56B | 47.33B | 53.21B | 66.28B | 46.39B |
| Total liabilities | 53,152,863,000.00 | 64,184,331,000.00 | 89,950,437,000.00 | 86,360,540,000.00 | 81,941,000,000.00 | 88,462,000,000.00 | 105,853,000,000.00 | 98,381,000,000.00 |
| Total equity | 5.65B | 3.94B | -3.87B | 6.20B | 6.11B | 3.28B | -4.28B | -16.50B |
| Retained earnings | -256.58M | 0 | -4.53B | -- | -- | -2.74B | -14.03B | -23.90B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 34.10B | 30.74B | 26.27B | 30.45B | 26.19B | 29.30B |
| Cash & ST investments | 13.03B | 10.30B | 7.41B | 11.84B | 5.50B | 5.93B |
| Inventory | 14.23B | 13.30B | 12.15B | 10.42B | 11.27B | 13.28B |
| Total assets | 95.42B | 91.30B | 87.38B | 81.88B | 75.87B | 79.24B |
| Total current liabilities | 25.90B | 25.47B | 22.35B | 40.22B | 36.91B | 38.00B |
| Short-term debt | 3.48B | 3.73B | 2.94B | 21.67B | 20.63B | 22.18B |
| Long-term debt | 62.15B | 58.65B | 57.15B | 46.39B | 44.12B | 42.92B |
| Total liabilities | 99,217,000,000.00 | 94,561,000,000.00 | 90,556,000,000.00 | 98,381,000,000.00 | 92,103,000,000.00 | 92,327,000,000.00 |
| Total equity | -3.80B | -3.26B | -3.17B | -16.50B | -16.23B | -13.09B |
| Retained earnings | -13.33B | -13.60B | -13.62B | -23.90B | -22.46B | -19.11B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 9.25B | 2.27B | 6.29B | 14.79B | 8.95B | -2.27B | 2.44B | -4.20B |
| Depreciation & amortization | 2.99B | 3.63B | 4.05B | 4.18B | 4.73B | 5.21B | 4.95B | 4.67B |
| Free cash flow | 6.54B | -417.25M | 3.53B | 11.37B | 4.10B | -6.80B | -1.33B | -7.33B |
| Dividends paid | -1.50B | -668.90M | -2.38M | -5.99B | -1.35B | -7.00M | -6.00M | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 5.55B | 6.80B | 13.86B | 8.68B | 12.47B | 14.19B | 14.99B | 10.50B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.33B | -287.00M | -682.00M | -900.00M | -4.25B | 29.00M |
| Depreciation & amortization | 1.19B | 1.24B | 1.09B | 1.16B | 1.17B | 1.16B |
| Free cash flow | -2.99B | -936.00M | -1.95B | -1.46B | -4.92B | -606.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 11.32B | 9.18B | 6.66B | 10.50B | 4.68B | 3.93B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 44.07 | -44.51 | -498.83 | 493.86 | -4.42 | -80.95 | -- | -- |
| ROA %i | 5.07 | -4.00 | -8.68 | 15.66 | -0.37 | -5.09 | -11.71 | -10.77 |
| ROIC %i | 9.47 | -3.14 | -8.93 | 26.80 | 2.18 | -3.91 | -- | -- |
| 5-year avg ROE %i | 40.62 | 29.54 | -86.51 | 16.03 | -1.97 | -26.97 | -- | -- |
| EBIT margin %i | 9.81 | -4.34 | -11.26 | 20.02 | 3.77 | -2.87 | -15.88 | 3.40 |
| FCF / sales %i | 11.28 | -- | 6.04 | 10.76 | 4.25 | -- | -- | -- |
| Current ratioi | 0.92 | 1.44 | 1.20 | 1.56 | 1.42 | 1.53 | 1.31 | 0.76 |
| Quick ratioi | 0.54 | 0.81 | 0.90 | 0.91 | 0.84 | 1.01 | 0.82 | 0.49 |
| Debt / assetsi | 64.59 | 65.09 | 70.23 | 58.56 | 61.13 | 65.30 | 72.58 | 87.10 |
| LT debt / equityi | 408.85 | 861.85 | -- | 661.65 | 690.18 | 1,406.89 | -- | -- |
| Interest coveragei | 2.73 | -0.98 | -2.13 | 6.63 | 1.01 | -0.49 | -2.26 | 0.46 |
| Revenue CAGR (3Y) %i | 7.35 | 3.16 | 5.92 | 22.12 | 22.64 | 6.43 | -9.84 | -9.85 |
| Net income CAGR (3Y) %i | -1.97 | -- | -- | 70.38 | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 20.35 | -- | 165.67 | 20.20 | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -9.82 | -6.17 | -5.82 | -10.77 | -10.66 | -6.50 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -11.76 | -4.86 | -6.74 | 3.40 | 3.87 | 9.43 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.32 | 1.21 | 1.18 | 0.76 | 0.71 | 0.77 |
| Quick ratioi | 0.75 | 0.67 | 0.60 | 0.49 | 0.38 | 0.42 |
| Debt / assetsi | 72.29 | 71.60 | 72.37 | 87.10 | 89.16 | 86.19 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -1.67 | -0.68 | -0.88 | 0.46 | 0.49 | 1.26 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Net sales and service revenue100.00%
Quote time 2026-10-08 10:11:19 · For reference only, not investment advice and not tailored to your situation.